# Invesco Health Care Fund

Invesco Health Care Fund is a registered fund series of AIM Investment Funds (Invesco Investment Funds) (series S000000235). Net assets $1.1B as of 2026-04-30.

## Profile

- Series ID: S000000235
- Registrant: AIM Investment Funds (Invesco Investment Funds)
- LEI: 549300BBEGFRGDDJRQ35
- Net assets: $1.1B
- Total assets: $1.2B
- As of: 2026-04-30

## Advisers

- [Invesco Advisers, Inc. (Advisor)](https://search.stillhousedata.com/firm/105360)
- [Invesco Asset Management (Japan) Ltd. (Subadvisor)](https://search.stillhousedata.com/firm/107155)
- [Invesco Senior Secured Management, Inc. (Subadvisor)](https://search.stillhousedata.com/firm/107590)
- [Invesco Hong Kong Ltd. (Subadvisor)](https://search.stillhousedata.com/firm/109923)
- [Invesco Asset Management Ltd. (Subadvisor)](https://search.stillhousedata.com/firm/109985)
- [Invesco Canada Ltd. (Subadvisor)](https://search.stillhousedata.com/firm/126572)
- [Invesco Management S.A. (Subadvisor)](https://search.stillhousedata.com/firm/143238)

## Top holdings (81 reported)

_Showing 15 of 81 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Eli Lilly and Co.](https://search.stillhousedata.com/security/532457108) | — | $109.2M | 965.19% |
| [Johnson & Johnson](https://search.stillhousedata.com/security/478160104) | — | $66.1M | 584.55% |
| [AstraZeneca PLC](https://search.stillhousedata.com/security/G0593M107) | — | $47.3M | 418.01% |
| [Gilead Sciences, Inc.](https://search.stillhousedata.com/security/375558103) | — | $44.1M | 389.78% |
| [UnitedHealth Group Inc.](https://search.stillhousedata.com/security/91324P102) | — | $42.9M | 378.85% |
| [argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $41.4M | 366.08% |
| [AbbVie Inc.](https://search.stillhousedata.com/security/00287Y109) | — | $40.9M | 361.81% |
| [McKesson Corp.](https://search.stillhousedata.com/security/58155Q103) | — | $38.8M | 342.68% |
| [Cencora, Inc.](https://search.stillhousedata.com/security/03073E105) | — | $35.2M | 311.57% |
| Invesco Private Prime Fund | — | $34.1M | 301.11% |
| [Welltower Inc.](https://search.stillhousedata.com/security/95040Q104) | — | $26.2M | 231.40% |
| [Merck & Co., Inc.](https://search.stillhousedata.com/security/58933Y105) | — | $25.6M | 226.69% |
| [BrightSpring Health Services, Inc.](https://search.stillhousedata.com/security/10950A106) | — | $23.1M | 204.46% |
| [Regeneron Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/75886F107) | — | $22.9M | 202.11% |
| [Royalty Pharma PLC](https://search.stillhousedata.com/security/G7709Q104) | — | $22.1M | 195.27% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $1.1B |
| 2026-01-31 | $1.2B |
| 2025-10-31 | $1.3B |
| 2025-07-31 | $1.1B |
| 2025-04-30 | $1.2B |
| 2025-01-31 | $1.3B |
| 2024-10-31 | $1.3B |
| 2024-07-31 | $1.4B |

## More

- [Registrant: AIM Investment Funds (Invesco Investment Funds)](https://search.stillhousedata.com/registrant/826644)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000000235.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.